MAGALCON PLUS ®– Magaldrate USP & Simethicone USP
COMPOSITION
Each 5ml contains Magaldrate 480 mg & Simethicone 20 mg.
PHARMACOLOGY
Magaldrate neutralizes gastric acid, thereby increasing pH of stomach and duodenal bulb. It also increases lower esophageal sphincter tone and inhibits smooth muscle contraction and gastric emptying. Simethicone lowers the surface tension of gas bubbles.
INDICATION
Hyperacidity, gastric and duodenal ulcer, gastritis, heartburn, dyspepsia, gastroesophalgeal reflux. It is also indicated for the relief of flatulence, abdominal distension and windy colic.
DOSGE AND ADMINISTRATION
Magalcon plus Suspension: 2-4 teaspoonfuls (10-20 ml) of suspension, 20 to 60 minutes after meals and at bed time, or as directed by the physician.
PREGNANCY AND LACTION
Pregnant women: Magaldrate may be used in pregnancy if indicated. However one should avoid excessive dosage.
Lactating mother: Magaldrate may pass into breast milk but has not been reported to cause problem in nursing babies.
CONTRAINDICATION
Intestinal obstruction, renal function impairment, appendicitis, chronic diarrhea, sensitivity to aluminium, magnesium amd simethicone.
SIDE EFFECT
Costipation, diarrhea, intestinal pain.
PRECAUTION
Should be cautions, if allergic to any ingredient to magaldrate and simethicone suspension, with a history of kidney problems or taking citrate salts (found in some calcium supplements, antacids and laxative). Do not take with tetracycline antibiotics. Antacids can interfere with the absorption of iron preparation.
STORAGE
Store in a cool, dry place & below 30° C. Protected from light. Keep out of reach of children.
PACKAGING
MAGALCON PLUS®: Suspension 200 ml: Each PET bottle contains 200ml suspension.